Chenodeoxycholic acid

Therapeutic Indications

Chenodeoxycholic acid is indicated for:

Sterol 27-hydroxylase deficiency, cerebrotendinous xanthomatosis (CTX)

Irrespective of gender only Adults (18 - 65 years old)

Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27-hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 750 mg in 3 divided doses daily

Sterol 27-hydroxylase deficiency, cerebrotendinous xanthomatosis (CTX)

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old) , Adolescents (12 years - 18 years old)

Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27-hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 5 mg/kg in 3 divided doses daily

Contraindications

Active ingredient Chenodeoxycholic acid is contraindicated in the following cases: